Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Tag Archives: biotechnology law
Patent Office Proposes New Materiality Rules
On July 21st, the Patent Office published a notice of proposed rulemaking, in the wake of the Therasense decision (a copy is found at the end of this post), awkwardly entitled “Revision of the Materiality to Patentability Standard for the … Continue reading
Judge Michel Takes “Patent Reform” Bills To Task
In an interview with Intellectual Property Watch, former Chief Judge Paul R. Michel set forth, in one place, all of the most problematic (Ed.: read, “worst”) features of the Leahy Smith America Invents Act, versions of which have been passed … Continue reading
BSC v. J & J – Written Description Requirement Spreads its Wings
On June 7th, in a Fed. Cir. panel decision written by Judge Moore, the panel affirmed the invalidation of four J&J patents (a copy of these patents is available at the end of this post) for failure to meet the … Continue reading
ACI v. Honda – Therasense in Practice
On June 27th, in American Calcar, Inc. v. American Honda Motor Co., Inc., No. 2009-1503, 1567 (Fed. Cir. June 27, 2011) the court reversed and remanded the district court’s findings of inequitable conduct in the obtainment of three patents relating … Continue reading